Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.

• Ralf Amann, Joerg Rohde, +4 authors Hanns-Joachim Rziha
• Journal of virology
• 2013

The present study describes the generation of a new Orf virus (ORFV) recombinant, D1701-V-RabG, expressing the rabies virus (RABV) glycoprotein that is correctly presented on the surface of infected… (More)

Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.

• Chengjin M Huang, Douglas Conlee, Michael Gill, Haiwen Chu
• Journal of feline medicine and surgery
• 2010

The duration of immunity of the dual-subtype feline immunodeficiency virus (FIV) vaccine, Fel-O-Vax FIV, for protection against subtype-B FIV was assessed in this study. Vaccinated cats along with… (More)

Efficacy and safety of a feline immunodeficiency virus vaccine.

• Chengjin M Huang, Douglas Conlee, Jennifer Loop, Deborah Champ, Mike Gill, Haiwen Chu
• Animal health research reviews
• 2004

Fel-O-Vax FIV is an inactivated virus vaccine designed as an aid in the prevention of infection of cats, 8 weeks or older, by feline immunodeficiency virus (FIV). It contains two genetically distinct… (More)

• ‹
• 1
• ›